Porphobilinogen, Quantitative
Understanding Porphobilinogen, Quantitative
What is Porphobilinogen, Quantitative?
Porphobilinogen, Quantitative test helps detect acute porphyrias such as acute intermittent porphyria (AIP). AIP is an autosomal dominant disorder caused by sudden changes (mutations) in porphobilinogen deaminase (PBGD), an enzyme that helps in hemoglobin formation. An acute attack usually presents with symptoms suggestive of gastrointestinal disturbances, such as abdominal pain, nausea, and vomiting along with occasional neuropsychiatric manifestations like peripheral neuropathy, and seizures. A few other symptoms that may be experienced include increased heart rate (tachycardia), dark-colored urine, etc. These symptoms may get precipitated by the use of certain medicines, infections, alcohol, infections, low caloric intake, reproductive hormone changes, etc. Avoiding precipitating factors and regular monitoring are some ways to prevent acute attacks of AIP.
What is Porphobilinogen, Quantitative used for?
The test is performed when either porphyria or an associated disorder is suspected due to the presence of certain symptoms such as pain in the limbs, backache, abdominal pain, rapid heart-beat, nausea and vomiting
Interpreting Porphobilinogen, Quantitative results
Interpretations
A normal test result indicates absence of PBG in urine sample and is considered as a negative test which implies that the symptoms caused are not due to porphyria but some other disorder. An abnormal result implies presence of PBG in high concentration.